PPIDT00112
Drug Information
| Name | Insulin aspart |
|---|---|
| Sequence | GIVEQCCTSICSLYQLENYCN |
| DrugBank_ID | DB01306 |
| Type | biotech |
| Indication | Insulin aspart is indicated to improve glycemic control in adults and children with diabetes mellitus.[L12273,L42550] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
100 [iU]/1mL
|
| Injection, solution | Subcutaneous |
600 nmol/ml
|
| Injection, solution | Intravenous; Subcutaneous |
600 nmol/ml
|
| Solution | Intravenous; Subcutaneous |
10000000 IU
|
| Injection, solution | Subcutaneous |
100 U/ML
|
| Injection, solution | Intravenous |
100 U/ML
|
| Injection | Parenteral |
100 U/mL
|
| Injection | Subcutaneous |
100
|
| Injection, solution | Intravenous; Subcutaneous |
100 [iU]/1mL
|
| Injection, suspension | Subcutaneous |
100 [iU]/1mL
|
| Injection, suspension | Parenteral; Subcutaneous |
100 U/ML
|
| Injection, suspension | Parenteral; Subcutaneous |
100 IU/ml
|
| Injection; injection, suspension | Subcutaneous |
100 IU/ml
|
| Suspension | Subcutaneous |
10000000 U
|
| Suspension | Subcutaneous |
0.7
|
| Injection, suspension | Subcutaneous |
|
| Injection | Subcutaneous |
|
| Injection | Subcutaneous |
100 U/mL
|
| Injection, suspension | Subcutaneous |
100 U/ml
|
| Suspension | Subcutaneous |
100 U/ml
|
| Injection | Subcutaneous |
100 IU/ml
|
| Injection, solution | Intravenous; Parenteral |
100 U/ML
|
| Injection, solution | Intravenous; Subcutaneous |
100 U/ml
|
| Injection, solution | Parenteral; Subcutaneous |
100 U/ML
|
| Injection; injection, solution | Subcutaneous |
100 IU/ml
|
| Solution | Subcutaneous |
100 U
|
| Solution | Subcutaneous |
100 unit / mL
|
| Injection, solution | Subcutaneous |
|
| Injection | Intravenous; Subcutaneous |
100 u/ml
|
| Solution | — |
100 U/ml
|
| Solution | Subcutaneous |
|
| Injection, solution | Subcutaneous |
|
| Injection | — |
|
| Injection, solution | Subcutaneous |
180 nmol/ml
|
| Solution | Intravenous; Subcutaneous |
100 unit / mL
|
| Injection, solution | — |
100 iu/1ml
|
| Injection, suspension | — |
|
| Suspension | Subcutaneous |
|
| Solution | — |
100 iu/1ml
|
Target Information